What are the characteristics of steatorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Steatorrhea

Steatorrhea is characterized by bulky, pale, malodorous, and floating stools due to excess fat content, typically defined as >7% of ingested fat present in stool or a coefficient of fat absorption <93%. 1

Clinical Presentation

  • Steatorrhea is the cardinal clinical feature of exocrine pancreatic insufficiency (EPI) and presents with visible fat in the stool 1
  • Stools are typically bulky, pale/light-colored, malodorous, and float due to their high fat content 1
  • Associated symptoms often include flatulence, bloating, dyspepsia, urgency to pass stools, and cramping abdominal pain 1
  • Weight loss is a common accompanying feature, especially in severe cases 1
  • Steatorrhea may be accompanied by deficiencies in fat-soluble vitamins (A, D, E, K) even in patients with mild to moderate pancreatic insufficiency 1

Diagnostic Criteria

  • Formally defined as >7% of ingested fat present in the stool or a coefficient of fat absorption <93% 1
  • Visible steatorrhea usually requires moderate fat in the diet and is typically not expected unless there is severe or decompensated pancreatic exocrine insufficiency 1
  • Quantitative measurement requires a diet of known fat content ingested over 5 days with stool collection during the final 3 days 1
  • Fecal fat exceeding 13 g/day (47 mmol/day) is considered severe steatorrhea and is most frequently caused by pancreatic exocrine insufficiency 1

Diagnostic Testing

  • Quantitative fecal fat testing is rarely needed in routine clinical practice and is burdensome to implement 1
  • Fecal elastase-1 (FE-1) is the most commonly used indirect pancreatic function test due to being simple, noninvasive, and relatively inexpensive 1
    • FE-1 <200 mg/g of stool is considered abnormal
    • FE-1 <100 mg/g is more consistent with EPI
    • FE-1 <50 mg/g is most reliable for severe EPI 1
  • Stool fat measures including Sudan stain are nonspecific for EPI but can help identify the presence of fat 1
  • Clinical assessment of steatorrhea by stool inspection alone is unreliable 1

Common Causes

  • Pancreatic exocrine insufficiency (EPI) is the most common cause of severe steatorrhea 1
    • Chronic pancreatitis
    • Pancreatic carcinoma
    • Pancreatic surgery
    • Cystic fibrosis
  • Small bowel disorders 1
    • Celiac disease
    • Crohn's disease
    • Small bowel bacterial overgrowth
    • Whipple's disease
    • Tropical sprue
  • Surgical causes 1
    • Small bowel resections
    • Bariatric surgery (especially malabsorptive procedures like BPD-DS) 1
  • Bile acid malabsorption 1
  • Liver disease (found in up to 78.3% of patients with various liver diseases) 2

Clinical Pearls and Pitfalls

  • Steatorrhea may not be clinically apparent in milder forms of malabsorption 1
  • Non-specific symptoms like bloating, excess gas, and foul-smelling or floating stools may respond to pancreatic enzyme replacement therapy (PERT), but these symptoms are non-specific and improvement may be due to placebo effect 1
  • Appropriate testing (e.g., fecal elastase) is recommended before initiating therapy with PERT to avoid masking other disorders such as celiac disease 1
  • Cross-sectional imaging (CT, MRI, endoscopic ultrasound) cannot directly identify EPI but can help evaluate for underlying pancreatic abnormalities 1
  • Steatorrhea after bariatric surgery may lead to deficiencies in fat-soluble vitamins, zinc, copper, and magnesium 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Steatorrhea in patients with liver disease.

Canadian Medical Association journal, 1971

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.